Please login to the form below
US trade deal
This page shows the latest US trade deal news and features for those working in and with pharma, biotech and healthcare.
UK’s Competition and Markets Authority to review AZ/Alexion merger
While the CMA has announced its intention to scrutinise the deal, the US Federal Trade Commission (FTC) has already cleared the proposed acquisition. ... on whether the deal is cleared or if it progresses to an additional ‘phase 2’ review.
Latest news
-
Biologic patent exclusivity scrapped in new US trade deal
Drugmakers dealt a blow in latest trade negotiations. The pharmaceutical industry has been dealt a blow in the latest negotiations for a new North American trade deal, after an agreement was ... According to Politico, the compromise in the terms of the
-
Labour clashes with government on ‘NHS for sale’ claims
Government maintains NHS will remain off the table in negotiations. Jeremy Corbyn has claimed that drug pricing changes and extending patent life feature prominently in UK-US trade talks, showing that – ... It insists the documents stem from a
-
NHS leader warns politicians not to ‘weaponise’ the health service
Another major issue is the possibility that the NHS would be paying a significant amount more than usual for its annual drugs spending if a UK-US trade deal is agreed ... deal with the US will have to pay higher prices for American drugs.
-
Trump backtracks on ‘NHS on the table’ comments
Echoes mixed message at home about healthcare. After creating a furore yesterday by suggesting that everything would be on the table in a post-Brexit US-UK trade deal – including access ... deal. He replied: “I think everything with a trade deal is
-
Hancock says “NHS not for sale” in post-Brexit US trade talks
Tensions rise as President Trump arrives for state visit. Freer access to the NHS will be part of any post-Brexit US-UK trade deal, according to US Ambassador Woody Johnson. ... Shadow Health Secretary Jonathan Ashworth also expressed his concern at the
More from news
Approximately 2 fully matching, plus 9 partially matching documents found.
Latest appointments
-
European Commissioner for health and food safety elected
US trade and investment deal could pose to people's health.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- MHRA to introduce new UK clinical trials framework
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- NHS England announces rare genetic disorder fast-tracking service
- NICE sees ‘promise’ in four UTI tests that could help in fight against AMR
- Connectome competitiveness
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Trust me, I’m from pharma
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- Sobi’s Kineret granted FDA Emergency Use Authorisation for COVID-19 related pneumonia
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 950 experts delivering world-class...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
